![]() | Only 14 pages are availabe for public view |
Abstract Venous thromboembolism (VTE) is a leading cause of hospital-related deaths worldwide. However, the proportion of patients at risk of VTE who receive appropriate prophylaxis in Egypt is unknown. Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), is a common and severe complication of critical illness Among the general medical ICU population, the incidence of DVT ranges between 13% to 24% in the first week of admission, PE is one of the three most frequently underdiagnosed illnesses identified during autopsies. Autopsy studies detected PE in 7 to 27 % of critically ill patients; of these, only one-third were clinically suspected. ICU patients share similar general risk factors for VTE with other patients as: age, immobilization, obesity, past history of personal or familial VTE, past history of neoplasm, sepsis, stroke, respiratory or heart failure, pregnancy, trauma, or recent surgery. Additional, specific risk factors for the ICU population have also been described as: Mechanical ventilation, central venous catheterization, platelet transfusion and vasopressor administration. Venous thrombus formation and propagation is associated with one or more of the following elements, collectively known as Virchow’s triad: venous stasis, blood vessel wall trauma or abnormality and increased risk of blood coagulation. A venous thromboembolism (VTE) prevention protocol is a standardized VTE risk assessment linked to a menu of appropriate VTE prophylaxis options for each level of risk. This protocol provides guidance for management of patients with contraindications to pharmacologic prophylaxis. Bleeding risk tools and guidance for the timing of administering anticoagulant prophylaxis around surgical procedures or other high bleeding risk intervals should also be part of a protocol. Having identified which patients are at risk of venous thromboembolism, the next choice for the physician is to select the most appropriate prophylactic measure for the patient circumstances. The ideal primary prophylactic should be effective, free from clinically important side effects, and well accepted by patients, nurses and medical staff. It should be easy to administer, relatively inexpensive and require minimal monitoring. There are two general types of prophylaxis: mechanical and pharmacological, Anticoagulants are the corner stone in both prevention and treatment of VTE. Root cause is defined as the most basic reason for undesirable condition which, if corrected, would have prevented it from existing. So Root cause analysis (RCA) refers to the process to identifying these casual factors. Root cause analysis initially developed to analyze Industrial accidents, now in medicine RCA is widely deployed as a cause analysis tool in health care Root Cause Analysis explores the how, the what and most importantly the why of patient safety incidents. The technique uses a structured process to move beyond identifying what went wrong and helps identify the contributory factors and root causes of patient safety incidents using a number of tools and techniques. Organizations are required to investigate all inpatient VTE events using root Cause analysis methodology where specific questions can be posed which relate to VTE risk assessment, prophylaxis and patient involvement, eventually allows them to actively learn from venous thromboembolism incidents and improving patient safety. The studies show low levels of VTE knowledge existed throughout the system. No one felt directly responsible for VTE risk assessment or for putting an action plan based on the risk assessment. Here comes the role of root cause analysis. By applying RCA it highlights the importance of continuous training, risk assessment to prevent VTE and to understand the significance of the procedure to ensure that VTE preventative measures are administered also it is essential that medical staff acknowledge that VTE prevention is the responsibility of everyone involved in a patient’s care. |